Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 9221
Corporate User License Price USD 375
Corporate User License Price INR 27664
Site License Price USD 250
Site License Price INR 18443
Request a Quote

Report Title

Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review



Executive Summary

Ypsomed Holding AG (YPSN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers its solutions to physicians, and pharmaceutical and biotechnology companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through its subsidiaries and distributors across the world. Ypsomed operates along with its subsidiaries in Europe, Asia and Australia. Ypsomed is headquartered in Burgdorf, Switzerland.

Ypsomed Holding AG Key Recent Developments

Jun 29,2018: Topping-out ceremony at the new Ypsomed site in Schwerin

Jun 27,2018: Change in the Board of Directors of the Ypsomed Group

May 24,2018: Ypsomed significantly increases turnover and invests more in the future

Mar 05,2018: Swisscom And Ypsomed Test 5G In Production Operations

Nov 09,2017: Ypsomed Grows during First half-year and Raises its Forecast for the Year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Ypsomed Holding AG-Key Facts 6

Ypsomed Holding AG-Key Employees 7

Ypsomed Holding AG-Key Employee Biographies 8

Ypsomed Holding AG-Major Products and Services 9

Ypsomed Holding AG-History 11

Ypsomed Holding AG-Company Statement 14

Ypsomed Holding AG-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

Company Overview 16

Ypsomed Holding AG-Business Description 17

Business Segment: Others 17

Overview 17

Performance 17

Business Segment: Ypsomed Delivery Systems 17

Overview 17

Performance 17

Business Segment: Ypsomed Diabetes Care 18

Overview 18

Performance 18

Geographical Segment: Europe 18

Performance 18

Geographical Segment: North America 18

Performance 18

Geographical Segment: Rest of the world 18

Performance 18

Geographical Segment: Switzerland 18

Performance 18

R&D Overview 19

Ypsomed Holding AG-Corporate Strategy 20

Ypsomed Holding AG-SWOT Analysis 21

SWOT Analysis-Overview 21

Ypsomed Holding AG-Strengths 21

Ypsomed Holding AG-Weaknesses 22

Ypsomed Holding AG-Opportunities 23

Ypsomed Holding AG-Threats 24

Ypsomed Holding AG-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Ypsomed Holding AG, Medical Equipment, Deals By Type, 2012 to YTD 2018 34

Ypsomed Holding AG, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin 36

Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group 37

May 24, 2018: Ypsomed significantly increases turnover and invests more in the future 38

Nov 09, 2017: Ypsomed Grows during First half-year and Raises its Forecast for the Year 40

Oct 24, 2017: Ypsomed supplies Bigfoot Biomedical with infusion sets 42

Sep 27, 2017: Go-ahead for Ypsomed's new production facility in Schwerin 43

May 24, 2017: Ypsomed accelerates growth significantly 44

May 10, 2017: Ypsomed expands to more countries 46

Jan 25, 2017: Ypsomed opens a new production line in Solothurn 47

Jan 12, 2017: Ypsomed honoured as successful company with future-oriented work models 48

Section 6-Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Ypsomed Holding AG, Performance Chart (2014-2018) 30

Ypsomed Holding AG, Ratio Charts 32

Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Ypsomed Holding AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 34

List of Tables

Ypsomed Holding AG, Key Facts 6

Ypsomed Holding AG, Key Employees 7

Ypsomed Holding AG, Key Employee Biographies 8

Ypsomed Holding AG, Major Products and Services 9

Ypsomed Holding AG, History 11

Ypsomed Holding AG, Subsidiaries 15

Ypsomed Holding AG, Key Competitors 25

Ypsomed Holding AG, Ratios based on current share price 26

Ypsomed Holding AG, Annual Ratios 27

Ypsomed Holding AG, Annual Ratios (Cont...1) 28

Ypsomed Holding AG, Annual Ratios (Cont...2) 29

Ypsomed Holding AG, Interim Ratios 31

Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Ypsomed Holding AG, Medical Equipment, Deals By Type, 2012 to YTD 2018 34

Ypsomed Holding AG, Recent Deals Summary 35

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Sanofi

Novo Nordisk AS

Medtronic Plc

Johnson & Johnson

F. Hoffmann-La Roche Ltd

Eli Lilly and Co

Abbott Laboratories

Ypsomed Holding AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand